publication date: Mar. 6, 2020
Forecasts of the inevitable spread of coronavirus can be difficult to ignore, especially at a time when many of us are making travel plans for this spring’s big cancer meetings.
Howard McLeod, one of the six researchers ousted at Moffitt Cancer Center under allegations of undisclosed conflicts of interest stemming from their work in China, is publicly disputing his former employer’s characterization of his involvement with academic institutions there.
By Electra D. Paskett, Ph.D.
In 1989, I joined Cancer and Leukemia Group B and was introduced into the clinical trials world and a mighty force for good, Dr. Clara D. Bloomfield.
- Roswell Park signs on to participate in ASCO’s CancerLinQ
- IASLC names research award after Fred R. Hirsch
- Dunmire, Godfrey, Nissenbaum named to LLS leadership team
- Research!America: Republicans, Democrats should prioritize research investment
- John Sampson named president of the Duke Health physician practice
- 49 cancer care facilities receive outstanding achievement award from American College of Surgeons Commission on Cancer
- Fox Chase Cancer Center announces name, recertification for Palliative Care Program
- Cancer survival rates improve for young adults
- Colorectal cancer burden shifts to younger adults
- Phase III BOSTON study meets primary endpoint with significant increase in PFS
- Keytruda meets PFS primary endpoint in phase III KEYNOTE-204
- From scorpion to immunotherapy: City of Hope scientists repurpose toxin for first-of-its kind CAR-T cell therapy for brain tumors
- VBI Vaccines phase I/II study demonstrates OS benefit for VBI-1901 vaccine responders in recurrent GBM
- FDA approves Sarclisa in patients with previously treated MM
- FDA grants RMAT designation for CD30 CAR-T cell therapy in Hodgkin lymphoma indication
- FDA grants tipifarnib Fast Track designation in T-cell lymphomas
- Thermo Fisher Scientific to acquire QiagenN.V.
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.